- Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysisPeter Stadler
Department of Radiotherapy and Radiation Oncology, University Hospital Regensburg, Germany
BMC Cancer 6:279. 2006..We retrospectively analyzed the efficiency and toxicity of the Regensburg standard therapy protocol "SCHARC" and the overall survival of our patients...
- Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literatureKurt Putnik
Department of Radiation Oncology, University of Regensburg, Josef Strauss Allee 11, 93053 Regensburg, Germany
Radiat Oncol 1:32. 2006..Moreover, some phototoxic drugs seem to enhance side effects of radiotherapy while others do not. We report a case of "radiation recall dermatitis" (RRD) one year after RT as a result of taking hypericin (St. John's wort)...